BPH: Magnus Heystek; Understanding Aveng consolidation; Sakeliga, NEASA on vaccine mandates in light of milder Omicron.

Loading player...
In this episode of the BizNews Power Hour Magnus Heystek explains what two big developments of the past 24 hours mean for investors - Govt's Parliamentary defeat on its Constitutional changing proposal and its batting away of the mandatory vaccine suggestion from Big Business; Richard Hirsch runs us through the Aveng 500-for-1 consolidation which took effect today; plus in-depth interviews with Sakeliga's Piet le Roux and Russell Lamberti; and NEASA's Gerhard Papenfus on how independent businesses are viewing vaccine mandates - and EWC. Learn more about your ad choices. Visit megaphone.fm/adchoices
8 Dec 2021 11AM English South Africa Investing · Business News

Other recent episodes

BNC#8: Melanie Veness on SA’s crisis - corruption, broken systems & a path forward

In a brutally honest keynote, Melanie Veness takes listeners to the frontline of South Africa’s economic crisis - where broken municipalities, failing infrastructure and political interference are no longer abstract problems, but daily battles. From chambers stepping in to fix water leaks and fight tariff abuse in court, to the…
24 Mar 7AM 22 min

BNC#8: Herman Mashaba on South Africa’s collapse - “Fix Johannesburg or lose everything!”

Speaking at BNC#8 in Hermanus, Herman Mashaba delivered a hard-hitting critique of South Africa’s collapsing governance, rising corruption, and eroding personal freedoms. From failing municipalities to unchecked crime, he argues the rule of law is under siege. Outlining bold reforms and his “Operation Fix Johannesburg,” Mashaba positions decisive leadership, accountability,…
24 Mar 5AM 21 min

Dr Kelvin Kemm: How “secure” is SA’s enriched uranium?

There are growing fears that nuclear weapons could be used in the Iran war. That has brought renewed focus on that 2007 attempted armed robbery at South Africa's nuclear research site, Pelindaba, and the “security” of the country’s large, high-quality enriched uranium stock. Chris Steyn asks Dr. Kelvin Kemm, a…
23 Mar 10AM 21 min